Kurs BioHemp International, Inc. Other OTC
Aktien
A2N8AM
US09076B1052
BKIT
Pharmazeutika
Manager | Titel | Alter | Seit |
---|---|---|---|
Daniel Blum
CEO | Chief Executive Officer | 35 | 15.05.19 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Daniel Blum
CEO | Chief Executive Officer | 35 | 15.05.19 |
% 1. Jan. | Kap. | |
---|---|---|
+33.50% | 701 Mrd. | |
+26.24% | 571 Mrd. | |
+0.78% | 381 Mrd. | |
+20.85% | 334 Mrd. | |
+16.38% | 319 Mrd. | |
+2.63% | 210 Mrd. | |
+1.00% | 210 Mrd. | |
-6.71% | 201 Mrd. | |
-3.51% | 157 Mrd. |